Relay Therapeutics
Quarterly Financials
| Values in thousands | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
|---|---|---|---|---|
Revenue | $350 | $3,000 | $7,000 | $0 |
Gross Profit | 350 | 2,496 | 6,401 | -67,889 |
EBITDA | -82,843 | -72,787 | -57,848 | -73,401 |
EBIT | -83,707 | -73,291 | -54,890 | -74,149 |
Net Income | -83,707 | -73,291 | -54,890 | -74,149 |
Net Change In Cash | 350 | 3,000 | 7,000 | 0 |
Free Cash Flow | -54,109 | -51,112 | -44,866 | -62,118 |
Cash | 121,189 | 204,589 | 84,018 | 91,564 |
Basic Shares | 202,849 | 179,849 | 171,586 | 172,389 |
Annual Financials
| Values in thousands | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
Revenue | $15,355 | $10,007 | $25,546 | $1,381 |
Gross Profit | 11,798 | -305,434 | -300,841 | -241,624 |
EBITDA | -272,922 | -380,210 | -374,153 | -306,822 |
EBIT | -276,479 | -385,674 | -379,422 | -310,952 |
Net Income | -276,479 | -337,708 | -341,973 | -290,509 |
Net Change In Cash | 15,355 | 10,007 | 25,546 | 1,381 |
Cost of Revenue | -128,325 | |||
Free Cash Flow | -235,865 | -251,125 | -304,442 | -238,552 |
Cash | 84,018 | 124,287 | 143,736 | 151,794 |
Basic Shares | 171,586 | 142,867 | 122,576 | 112,233 |
Earnings Calls
| Quarter | EPS |
|---|---|
2026-06-30 | -$0.41 |
2026-03-31 | -$0.41 |
2025-12-31 | -$0.32 |
2025-09-30 | -$0.43 |